<html>
<head>PUBMED IDs for ARVD5</head>
<body bgcolor='#C5F0F2'><h1>ARVD5</h1><a href='https://pubmed.ncbi.nlm.nih.gov/18313022/'>Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18312935/'>Tumor necrosis factor-related apoptosis inducing ligand-R4 decoy receptor expression is correlated with high Gleason scores, prostate-specific antigen recurrence, and decreased survival in patients with prostate carcinoma.</a> March 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20010364/'>Translation of research discoveries to clinical care in arrhythmogenic right ventricular cardiomyopathy in Newfoundland and Labrador: lessons for health policy in genetic disease.</a> March 6  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/23161701/'>Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and Canada.</a> September 21  2012<br></body></html>
